Physician profile
William Rhead
NPI 1861445512
$41,356.25
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 84% of Clinical Genetics (M.D.) providers received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $624 · 2021: $309 · 2022: $327 · 2024: $28K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $22.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,767.00 |
| Food and Beverage | $22.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $36,000.00 | 2024-2025 | |
| Travere Therapeutics, INC. | $3,500.00 | 2025 | |
| Sentynl Therapeutics, INC. | $910.00 | 2020-2022 | |
| Genzyme Corporation | $350.00 | 2020 | |
| Alnylam Pharmaceuticals INC. | $306.67 | 2019 | |
| Dr.Reddy'S Laboratories,INC. | $267.00 | 2024 | |
| Mirum Pharmaceuticals, INC. | $22.58 | 2024 | Livmarli |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rhead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.